Podcast: Play in new window | Download
Subscribe: Google Podcasts | RSS
Dr. Jeff Chen is the Co-founder and CEO of Radicle Science, a health tech company generating history’s first dataset and AI to prove and predict the effects of health and wellness products. Previously, he was the Founder and Exec Director of the UCLA Cannabis Research Initiative.
At CannMed 2022, Dr. Chen presented results for Radicle Health’s ACES study, a randomized clinical trial, involving 13 CBD products and 3,000 participants. The project was possible thanks to Radicle Science’s unique, virtual approach to clinical trials, which removes many challenges that make them expensive and difficult to conduct.
Topics covered during the conversation include:
- The many challenges associated with performing clinical trials on cannabinoids
- How a virtual, direct-to-consumer approach overcomes many of those challenges
- The value brands, manufacturers, and distributors get from clinical trial data
- Results from the ACES Study, the largest randomized CBD clinical trial in history
- How Radicle applied lessons learned from ACES study to design the Radicle Spectrum study
- Other minor cannabinoids that Radicle Science is investigating and which have the most therapeutic potential
Thanks to This Episode’s Sponsor: Planetarie
Female-founded Planetarie is truly plant-based wellness designed to keep you moving and playing. Planetarie created a water-based, hemp extraction method and built a vertically integrated company with USDA-organic certified products made from that full-spectrum stable CBDa. The answer for plant-based anti-inflammation is found in Nature, beautifully harnessed with science.
Additional Resources